Free provider profile
DONALD TAYLOR, NP
LOS ANGELES, CA
Find similar providers: Nurse Practitioner, Psych/Mental Health in LOS ANGELES, CA
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
626-757-4974
Practice address
2523 W 7TH ST ENKI HEALTH & RESEARCH SYSTEMS, INC. PICO UNION, LOS ANGELES, CA, 90057
Fax not published.
- Registry updated
- 2016-10-25
- NPI issued
- 2007-07-20
- RepVector retrieved
- 11/22/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Nurse Practitioner, Psych/Mental Health
363LP0808X
PrimaryRehabilitation Practitioner
225400000X
Registered Nurse, Psych/Mental Health
163WP0808X
1 registered practice location · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like DONALD TAYLOR?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What DONALD TAYLOR prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Invega Sustenna
- Vraylar
- Lurasidone Hcl
- Seroquel Xr
- Abilify Maintena
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,780
Medicare patients
88
Part D drug cost
$457,502
Brand-name share
8.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Invega Sustenna (Paliperidone Palmitate) | 29 | $84,295 |
| Vraylar (Cariprazine Hcl) | 23 | $63,485 |
| Abilify Maintena (Aripiprazole) | 20 | $49,173 |
| Rexulti (Brexpiprazole) | 20 | $30,446 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 16 | $26,765 |
| Seroquel Xr (Quetiapine Fumarate) | 21 | $14,144 |
| Lurasidone Hcl (Lurasidone Hcl) | 23 | $10,254 |
| Clozapine (Clozapine) | 13 | $4,649 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across CA — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
